TrialAnnals of hematology2013

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.

C Binder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.